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LElTERS TO THE EDITORS 
Circumventing antibiotic resistance in 
specialized hospital units 
Clin Microbiol Infect 1997; 3: 133-134 
Sanders and Sanders [l] introduced the idea of cycling 
antibiotics on special care units to circumvent the 
emergence of resistance in bacterial pathogens. The 
salient features of such an antibiotic cycling program, 
which include infection control procedures, elimina- 
tion or avoidance of certain antibiotics and also con- 
tinuous education and monitoring, were pointed out. 
As I understand the intention, the ideas presented in 
the paper were advanced to stimulate discussion, as no 
controlled trials were quoted to prove the efficacy of 
the strategy. Indeed, it might be difficult to devise a 
suitable control group. 
What can happen to an antibiotic cycling program? 
To describe the worst scenario: within a few months of 
the introduction of such a cycling program, the staff 
will be disillusioned because nobody wdl remember 
which cycled regimen is in force, there being so many 
other tasks that have to be undertaken and regulated in 
intensive care units. It can also be foreseen that within 
a short period of time (less than 2 years of cycling), 
strains of multidrug-resistant Pseudomonas aeruginosa 
or Enterobacter spp., producing inducible p-lactamases 
and/or extended-spectrum p-lactamases with a loss or 
alteration of outer-membrane proteins, will invalidate 
this very mechanistic cycling process. 
In my personal experience, there may be at least 
one other way to handle infections in patients on 
special care units to avoid or to postpone the emer- 
gence of resistance. Based upon results of microbio- 
logical investigations, it is possible to create not what is 
called in the paper an ‘empirical’ but rather a ‘calculated’ 
chemotherapy for different sites of infection, e.g. blood, 
lung, abdomen, wound, urinary tract. 
The rules for such a calculated chemotherapy have 
to be elaborated co-operatively by clinicians, micro- 
biologists and pharmacists, and have to take into 
account five different aspects: prevalence of pathogens 
at a given site of infection; susceptibility patterns of 
these pathogens; pharmacokinetic aspects, including 
dosing; the condition of the patient (e.g. immuno- 
suppression, renal function); and costs. On the basis 
of these data, it is possible to create very different 
therapeutic regimens tailored to the special require- 
mentsdictated by the local epidemiologic situation, 
the site of infection and the individual patient charac- 
teristics-which can be used in parallel, thus avoiding 
the impact of a single regimen over even a short period 
of time on selection of resistance. It is possible to use 
ureidopenicillins, second-generation cephalosporins, 
and in some cases third-generation cephalosporins, as 
well as aminoglycosides or potent fluoroquinolones 
such as ciprofloxacin. It is important to adapt the 
regimens to the local situation. For example, in many 
of the small or medium-sized hospitals in Germany, 
infections by methicillin-resistant Staphylococcus aureus 
(MRSA) are uncommon and emergence of resistance 
in MRSA to fluoroquinolones does not present so great 
a threat as it may do elsewhere. 
During the time that the guidelines are in use, the 
results of culture must be monitored very carefully by 
the microbiologist on a continuous basis, to detect all 
possible resistance mechanisms in the pathogens iso- 
lated. This should be done in ‘real time’, to give early 
warning of the emergence of resistant strains. When 
this happens, it is time to change the guidelines of 
calculated chemotherapy. The analysis should show not 
only the susceptibilities of first isolates from individual 
patients but also those of subsequent isolates, to 
determine whether resistance m y  develop during treat- 
ment. A further point is the need for rapid micro- 
biological results; for several years it has been possible 
in many cases to obtain f d  results within 24 h [2]. 
There are even some data showing that rapid micro- 
biological results may improve survival of patients [3] .  
By introducing these methods, it is possible to shorten 
the period of calculated chemotherapy and to switch to 
individualized chemotherapy, eliminating carbapenems 
or third- and fourth-generation cephalosporins when- 
ever possible. Rapid microbiology sigmficantly decreases 
selective pressure by avoiding overuse of highly efficient 
antibiotics. 
My personal opinion is that microbiologists should 
promote such varied therapeutic regimens in co- 
operation with clinicians and pharmacists. For fhure 
investigation I would propose to take patients on a 
regimen of calculated chemotherapy in combination 
with rapid microbiology as a control group to compare 
with a group of patients on wards which have adopted 
cycling therapy. 
Wo&ang R. Heizmann 
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Incidence of Bi/ophi/a wadsworfhia in appendiceal, 
peritoneal and fecal samples from children 
Clin Microbiol Infect 1997; 3: 134-136 
In the course of their studies on appendicitis, Baron and 
coworkers recovered a new anaerobic rod, which was 
isolated from about 50% of the appendiceal samples 
from patients with complicated appendicitis and which 
was described in 1989 as Bilophila wadsworthia [l]. The 
lower intestinal tract seems to be the natural habitat of 
B. wadsworthia, where it was recovered from 60% of 
the subjects, with counts ranging from 3 ~ 1 0 ~  to 
2 x 108/g stool. Additionally, B. wadsworthia was isolated 
from 4% of saliva samples and from 3% of vaginal 
specimens from healthy volunteers [2]. Quite recently, 
B. wadsworthia has been described also in other infec- 
tious processes, such as scrotal abscess, mandibular 
osteomyelitis, pleural empyema and bacteremia, suggest- 
ing that B. wadsworthia is capable of acting as a pathogen 
[3-51. There are no reports about the occurrence of 
B. wadsworthia in clinical specimens or in feces from 
children. 
Included in this study were 229 children aged 3 
months to 15 years, admitted to the department of 
pediatric surgery (University of Tiibingen) during a 
12-month period (6 January 1994 to 5 January 1995) 
because of acute abdominal pain in the right hypo- 
gastrium. Stool samples were taken from all patients. 
The main cause of abdominal pain was gastroenteritis 
(136 cases), but 51 of the children underwent appen- 
dectomy; in these patients the appendices were also 
studied. The appendices were divided lengthwise under 
sterile conditions for histopathologic and microbio- 
logical examination. According to the histopathologic 
findings and the visual assessment at surgery, seven cases 
were diagnosed as chronic appendicitis, 26 as acute 
or phlegmonous appendicitis and 14 as Complicated 
(gangrenous or perforated) appendicitis. In four cases 
appendectomy was performed in the presence of 
abdominal pathology other than appendicitis (Table 1). 
In cases with suspicious intraoperative findings, peri- 
toneal swabs were also examined (38 cases). 
Table 1 Data on patients undergoing surgery 
Type of appendicitis 
Negative Chronic Acute Complicated 
~~ 
No. 4 7 26 14 
Sex (M/F) 2/2 413 14/12 7/7 
Mean age (years) 8.2 11.7 10.0 9.3 
Mean WBC count 
Mean temperature 
at admission (per pL) 10 190 9385 15 134 17 820 
at admtssion (“C) 37.2 37.6 37.8 38.2 
In stool samples the occurrence of B. wadsworthia 
only was investigated from the appendix tissue only 
anaerobic isolates were recovered; and in peritoneal 
swabs aerobic and anaerobic organisms were isolated. 
The appenhceal samples were incubated on two 
Bacteroides-bile-esculin (BBE), brain-heart infusion 
(BHI) and kanamycin-vancomycin (KV) agar plates 
each. The peritoneal swab was used to inoculate plates 
of Columbia blood agar, Endo agar: BBE, BHI and KV 
agar and an enrichment broth. From each stool sample 
one loop was inoculated on two BBE plates. Media 
were incubated anaerobically (Anaerocult A, Merck) at 
37°C for at least 7 days. Blood and Endo agar plates 
were incubated aerobically at 37OC for at least 48 h. 
The identification of B. wadsworthia was by the 
following methods: Gram stain; detection of bile 
resistance; positive catalase reaction (5% H202); short- 
chain fatty acid analysis (detection of acetate) by 
gas-liquid chromatography; negative reactions for 
glucose fermentation, esculin hydrolysis and indole 
production; positive reactions for H2S production and 
nitrate reductase; and testing for urease activity. 
Cultures of the appendices yielded 293 strains of 
more than 44 different anaerobic species (Table 2). 
Bacteroides fragilis (62.7%) and B. wadsworthia (50.9%) 
were the anaerobic species most often isolated from 
appendiceal samples, followed by Bacteroides ovatus, 
Peptostreptococcus anaerobius, Peptostreptococcus micros and 
Prevotella intermedia. The results presented showed 
marked similarities between non-inflamed and chroni- 
cally inflamed appendices, in contrast to findings in 
acute and complicated appendicitis with respect to 
species and number of species of anaerobes recovered. 
Non-acutely inflamed appendices harbored on average 
four to five different anaerobic species, whereas in acute 
or complicated cases more than six Werent anaerobic 
species were identified. B. wadsworthia was recovered 
